News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Bayer Corporation Gains on Renewed Novartis Corporation Bid Talk
April 13, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Shares in Bayer rose on Tuesday with traders saying there is renewed market talk that Swiss rival Novartis might make a bid for Germany's largest drugmaker.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Bayer
MORE ON THIS TOPIC
Collaboration
GSK Joins Growing PD-1 SubQ Push With Alteogen Alliance Worth up to $285M+
January 21, 2026
·
1 min read
·
Tristan Manalac
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
January 21, 2026
·
1 min read
·
Heather McKenzie
Vaccines
Pfizer Makes $530M Vaccine Play With Novavax Deal After Rumors of BioNTech Pullback
January 20, 2026
·
1 min read
·
Tristan Manalac
CAR-T
AstraZeneca Pays $630M for Complete Global Rights Over AbelZeta’s CAR T
January 20, 2026
·
2 min read
·
Tristan Manalac
